Why is the world’s first universal coronavirus vaccine not in the FDA’s toolbox?
Success in any project is based on using the right tool for the job. No tool would be more effective in the campaign against COVID than Covaxin, which has shown its value in India and other markets during recent months.
While mRNA vaccines were a promising option in the early stages of the pandemic, a study released by the CDC on January 19, 2022 showed that in two of the most …